Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-039056

General Counsel and Secretary sold 1,597 shares at an average $28.37 ($45,311)

  • General Counsel and Secretary acquired 1,597 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Lara General Counsel and Secretary 2022-12-15 Option exercise +300 $23.03 $6,909 300 D
Meisner Lara General Counsel and Secretary 2022-12-15 Sale −300 $28.08 $8,424 0 D
Meisner Lara General Counsel and Secretary 2022-12-16 Option exercise +1,297 $23.03 $29,870 1,297 D
Meisner Lara General Counsel and Secretary 2022-12-16 Sale −1,297 $28.44 $36,887 0 D
Derivatives
Meisner Lara General Counsel and Secretary 2022-12-15 Option exercise · Stock Option (Right to Buy) −300 62,944 D
Meisner Lara General Counsel and Secretary 2022-12-16 Option exercise · Stock Option (Right to Buy) −1,297 61,647 D
Open-market sales · 1,597 sh · avg $28.37 · $45,311
Loading xslF345X03/doc4.xml…